US 20060247240A1
· Hoffmann et al.
· 2006
[cited by applicant]
US 20110053954A1
· Hoffmann et al.
· 2011
[cited by applicant]
CA 2831054A1
· 2013
[cited by applicant]
WO WO2008067610A1
· 2008
[cited by applicant]
WO WO2009009829A1
· 2009
[cited by applicant]
Kart-Teke et al., “Reinstatement of episodic-like memory in rats by neurokinin-1 receptor antagonism,” Neurobiol. Learn. Mem. Mar. 2007;87(3):324-31. PMID: 17079168. (Year: 2007).
[cited by examiner]
Wang et al., “Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration,” J. Alzheimers Dis. 2013;33 Suppl 1:S123-39. PMID: 22710920. (Year: 2013).
[cited by examiner]
Baugh et al., “Chronic traumatic encephalopathy: neurodegeneration following repetitive concussive and subconcussive brain trauma”, Brain Imaging and Behavior (2012) vol. 6, pp. 244-254.
[cited by applicant]
Baylock et al., “Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy—A unifying hypothesis,” Surg Nerurol Int. (2011) 2: 107 (Published online Jul. 30, 2011).
[cited by applicant]
Donkin et al., “Substance P is associated with the development brain edema and functional deficits after traumatic brain injury,” Journal of Cerebral Blood Flow & Metabolism, vol. 29, pp. 1388-1398 (2009) (Published onl…
[cited by applicant]
Donkin et al., “A Substance P Antagonist Reduces Axonal Injury and Improves Neurologic Outcome When Administered U to 12 Hours after Traumatic Brain Injury,” Journal of Neurotrauma, vol. 28, pp. 217-224 (Feb. 2011).
[cited by applicant]
Franz et al., “Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury”, Neurology (May 2013), vol. 60, No. 9, pp. 1457-1461.
[cited by applicant]
Gao et al., “Chronic Traumatic Encephalopathy-like Neuropathological Findings without a History of Trauma,” International Journal of Pathology and Clinical Research, (Jan. 2017) vol. 3(1) pp. 1-4.
[cited by applicant]
Gavett et al., “Mild traumatic brain injury: a risk factor for neurodegeneration,” Alzheimer's Research & Therapy, vol. 2, No. 18, pp. 1-3 (2010).
[cited by applicant]
International Search Report issued on Sep. 8, 2014 in application No. PCT/AU2014/050107.
[cited by applicant]
Johnson et al., “Acute and Chronically Increased Immunoreactivity to Phosphorylation-Independent but Not Pathological TDP-43 After a Single Traumatic Brain Injury in Humans,” Acta Neuropathol (Dec. 2011) vol. 122(6) pp.…
[cited by applicant]
McKee et al., “Chronic Traumatic Encephalopathy in Athletes: Progressive Tauopathy After Repetitive Head Injury,” J. Neuropathol. Exp. Neurol., vol. 68, No. 7, pp. 709-735 (Jul. 2009).
[cited by applicant]
McKee et al., “The Neuropathology of Chronic Traumatic Encephalopahty,” Brain Pathol. (May 2015) vol. 25, No. 3, pp. 350-364.
[cited by applicant]
Neal et al., “Concussions: What a neurosurgeon should know about current scientific evidence and management strategies,” Surgical Neurology International, vol. 3, No. 16, pp. (Feb. 2015).
[cited by applicant]
Office Action issued on Feb. 22, 2018 in U.S. Appl. No. 14/902,228 (US 2016-013160).
[cited by applicant]
Office Action issued on Mar. 22, 2017 in U.S. Appl. No. 14/902,228 (US 2016-013160).
[cited by applicant]
Office Action issued on Jul. 31, 2019 in U.S. Appl. No. 14/902,228 (US 2016-0136160).
[cited by applicant]
Office Action dated Sep. 18, 2017 in U.S. Appl. No. 14/902,228 (US 2016-0136160).
[cited by applicant]
Office Action issued on Apr. 8, 2020, in U.S. Appl. No. 14/902,228 (US 2016-0136160).
[cited by applicant]
Saulle et al., “Chronic Traumatic Encephalopathy: A Review,” Rehabilitation Research and Practice (2012) vol. 2012 pp. 1-9.
[cited by applicant]
Thornton et al., “Treatment with a Substance P Receptor Antagonist Is Neuroprotective in the Intrastriatal 6-Hydroxydopamine Model of Early Parkinson's Disease,” PLoS One, vol. 7, No., 4, e34138, pp. 1-8 (Apr. 2012).
[cited by applicant]
Tran et al., “Inhibition of JNK by a Peptide Inhibitor Reduces Traumatic Brain Injury-Induced Tauopathy in Transgenic Mice,” J. Neuropathol Exp Neurol., (Feb. 2012) vol. 71, No. 2 pp. 116-129.
[cited by applicant]